清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study

医学 急性肾损伤 肌酐 肾功能 优势比 内科学 肾脏疾病 临床终点 安慰剂 肾脏替代疗法 外科 入射(几何) 随机对照试验 泌尿科 病理 物理 替代医学 光学
作者
Matthias Thielmann,David Corteville,Gábor Szabó,Madhav Swaminathan,André Lamy,Lukas Lehner,Craig Brown,Nicolas Noiseux,Mohamed G. Atta,Elizabeth C. Squiers,Shai Erlich,Daniel Rothenstein,Bruce A. Molitoris,C. David Mazer
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:144 (14): 1133-1144 被引量:62
标识
DOI:10.1161/circulationaha.120.053029
摘要

Acute kidney injury (AKI) affects up to 30% of patients undergoing cardiac surgery, leading to increased in-hospital and long-term morbidity and mortality. Teprasiran is a novel small interfering RNA that temporarily inhibits p53-mediated cell death that underlies AKI.This prospective, multicenter, double-blind, randomized, controlled phase 2 trial evaluated the efficacy and safety of a single 10 mg/kg dose of teprasiran versus placebo (1:1), in reducing the incidence, severity, and duration of AKI after cardiac surgery in high-risk patients. The primary end point was the proportion of patients who developed AKI determined by serum creatinine by postoperative day 5. Other end points included AKI severity and duration using various prespecified criteria. To inform future clinical development, a composite end point of major adverse kidney events at day 90, including death, renal replacement therapy, and ≥25% reduction of estimated glomerular filtration rate was assessed. Both serum creatinine and serum cystatin-C were used for estimated glomerular filtration rate assessments.A total of 360 patients were randomly assigned in 41 centers; 341 dosed patients were 73±7.5 years of age (mean±SD), 72% were men, and median European System for Cardiac Operative Risk Evaluation score was 2.6%. Demographics and surgical parameters were similar between groups. AKI incidence was 37% for teprasiran- versus 50% for placebo-treated patients, a 12.8% absolute risk reduction, P=0.02; odds ratio, 0.58 (95% CI, 0.37-0.92). AKI severity and duration were also improved with teprasiran: 2.5% of teprasiran- versus 6.7% of placebo-treated patients had grade 3 AKI; 7% teprasiran- versus 13% placebo-treated patients had AKI lasting for 5 days. No significant difference was observed for the major adverse kidney events at day 90 composite in the overall population. No safety issues were identified with teprasiran treatment.The incidence, severity, and duration of early AKI in high-risk patients undergoing cardiac surgery were significantly reduced after teprasiran administration. A phase 3 study with a major adverse kidney event at day 90 primary outcome that has recently completed enrollment was designed on the basis of these findings (NCT03510897). Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02610283.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
墨言无殇完成签到 ,获得积分10
2秒前
传奇3应助清脆钧采纳,获得10
5秒前
17秒前
丘比特应助海藏进星辰采纳,获得10
23秒前
蝎子莱莱xth完成签到,获得积分10
23秒前
wbh发布了新的文献求助10
24秒前
辛勤的泽洋完成签到 ,获得积分10
26秒前
氢锂钠钾铷铯钫完成签到,获得积分10
30秒前
33秒前
Square完成签到,获得积分10
37秒前
47秒前
52秒前
树懒完成签到 ,获得积分10
53秒前
55秒前
鲑鱼完成签到 ,获得积分10
56秒前
习月阳完成签到,获得积分10
1分钟前
乒坛巨人完成签到 ,获得积分0
1分钟前
米奇妙妙屋完成签到,获得积分10
1分钟前
liaomr完成签到 ,获得积分10
1分钟前
1分钟前
celia完成签到 ,获得积分10
1分钟前
清脆钧发布了新的文献求助10
1分钟前
1分钟前
1分钟前
chcmy完成签到 ,获得积分0
1分钟前
livra1058完成签到,获得积分10
2分钟前
Hxq完成签到 ,获得积分10
2分钟前
阿曾完成签到 ,获得积分10
2分钟前
vitamin完成签到 ,获得积分10
2分钟前
dashi完成签到 ,获得积分10
2分钟前
无悔完成签到 ,获得积分10
2分钟前
LaTeXer应助feng采纳,获得200
2分钟前
胡国伦完成签到 ,获得积分10
2分钟前
善学以致用应助ceeray23采纳,获得20
3分钟前
wack发布了新的文献求助10
3分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
YifanWang应助科研通管家采纳,获得30
3分钟前
YifanWang应助科研通管家采纳,获得50
3分钟前
CipherSage应助科研通管家采纳,获得10
3分钟前
LeoBigman完成签到 ,获得积分10
4分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990603
求助须知:如何正确求助?哪些是违规求助? 3532220
关于积分的说明 11256532
捐赠科研通 3271057
什么是DOI,文献DOI怎么找? 1805229
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809234